In explaining the still theoretical area of bioelectronics or “electroceuticals” GlaxoSmithKline PLC’s Moncef Slaoui talks about how true breakthrough discoveries sometimes result from the interaction of scientific disciplines that don’t normally work or even converse with one another. The pharma has been working to nudge along the advancement of bioelectronics in recent years, with a $1 million research prize announced Dec. 18 its latest such effort.
GSK concluded its bioelectronic summit in New York this week, a global gathering of 150 leading scientists from different disciplines, by offering that cash prize to the first researcher who...